Wuxi BioHermes Biomedical Technology

BioHermes is a prominent medical technology company headquartered in Wuxi, China, specializing in the development and manufacture of in vitro diagnostic (IVD) systems. The company is a global leader in HbA1c testing, leveraging its proprietary boronate affinity chromatography platform to provide highly accurate diabetes monitoring solutions that are resistant to hemoglobin variant interference. Their extensive product portfolio includes automated laboratory analyzers, portable point-of-care testing (POCT) devices, and rapid diagnostic kits for infectious diseases such as COVID-19. BioHermes serves a wide range of clinical environments, from large hospitals to primary care clinics, across more than 100 countries. By integrating advanced biochemical research with precision engineering, the company continues to expand its diagnostic capabilities in metabolic and infectious disease management.